David J. Topper's most recent trade in Arcutis Biotherapeutics Inc was a trade of 9,600 Common Stock done at an average price of $15.8 . Disclosure was reported to the exchange on April 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc | David J. Topper | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.80 per share. | 02 Apr 2025 | 9,600 | 182,774 (0%) | 0% | 15.8 | 151,698 | Common Stock |
| Arcutis Biotherapeutics Inc | David J. Topper | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 89,000 | 89,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | David J. Topper | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 34,000 | 192,374 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | David J. Topper | Chief Financial Officer | 21 Sep 2024 | 60,000 | 170,000 (0%) | 0% | 0 | Common Stock | ||
| Arcutis Biotherapeutics Inc | David J. Topper | Chief Financial Officer | 21 Sep 2024 | 11,626 | 158,374 (0%) | 0% | 9.5 | 110,264 | Common Stock | |
| Arcutis Biotherapeutics Inc | David J. Topper | Chief Financial Officer | 10 Apr 2024 | 310,000 | 310,000 | - | - | Stock Option (right to buy) | ||
| Arcutis Biotherapeutics Inc | David J. Topper | Chief Financial Officer | 10 Apr 2024 | 110,000 | 110,000 (0%) | 0% | 0 | Common Stock |